Search research articles
Contact Us
Filters
Showing results (41-50 of 97) with videos related to
Page
of 10
Sort By:
Cancer Immunology Research
|
April 14, 2018
Secretory IgM Exacerbates Tumor Progression by Inducing Accumulations of MDSCs in Mice
Chih-Hang Tang, Shiun Chang, Ayumi Hashimoto, et al.
Haematologica
|
December 17, 2020
The impact of early discontinuation/dose modification of venetoclax on outcomes in patients with relapsed/refractory chronic lymphocytic leukemia: post-hoc analyses from the phase III MURANO study
Anthony R Mato, Jeff P Sharman, Juliana M L Biondo, et al.
American Journal of Hematology
|
May 18, 2017
Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis
Steven M Bair, Lauren Strelec, Sarah J Nagle, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 24, 2018
Interim PET/CT Result Is Not Predictive of Survival in Patients With MYC-rearranged Non-Burkitt Aggressive B-cell Lymphoma
Hua-Jay J Cherng, Rachel Lynn Sargent, Sunita Dwivedy Nasta, et al.
Leukemia & Lymphoma
|
June 7, 2006
A predictive model for the detection of tumor lysis syndrome during AML induction therapy
Anthony R Mato, Brett E Riccio, Li Qin, et al.
Leukemia & Lymphoma
|
June 28, 2021
Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality
Maximilian Stahl, Varun Narendra, Justin Jee, et al.
Cancer Biology & Therapy
|
December 14, 2007
Primary cardiac lymphoma: utility of multimodality imaging in diagnosis and management
Anthony R Mato, Alicia K Morgans, Michele R Roullet, et al.
American Journal of Hematology
|
March 26, 2016
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas
Clinton Yam, Daniel J Landsburg, Kevin T Nead, et al.
Cancer
|
December 20, 2011
Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD
Anthony R Mato, Jakub Svoboda, Tatyana Feldman, et al.
Cell Death & Disease
|
July 23, 2025
Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient
Johanne U Hermansen, Paschalis Athanasiadis, Yanping Yin, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 97) with videos related to
Sort By:
Page
of 10
Cancer Immunology Research
|
April 14, 2018
Secretory IgM Exacerbates Tumor Progression by Inducing Accumulations of MDSCs in Mice
Chih-Hang Tang, Shiun Chang, Ayumi Hashimoto, et al.
Haematologica
|
December 17, 2020
The impact of early discontinuation/dose modification of venetoclax on outcomes in patients with relapsed/refractory chronic lymphocytic leukemia: post-hoc analyses from the phase III MURANO study
Anthony R Mato, Jeff P Sharman, Juliana M L Biondo, et al.
American Journal of Hematology
|
May 18, 2017
Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis
Steven M Bair, Lauren Strelec, Sarah J Nagle, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 24, 2018
Interim PET/CT Result Is Not Predictive of Survival in Patients With MYC-rearranged Non-Burkitt Aggressive B-cell Lymphoma
Hua-Jay J Cherng, Rachel Lynn Sargent, Sunita Dwivedy Nasta, et al.
Leukemia & Lymphoma
|
June 7, 2006
A predictive model for the detection of tumor lysis syndrome during AML induction therapy
Anthony R Mato, Brett E Riccio, Li Qin, et al.
Leukemia & Lymphoma
|
June 28, 2021
Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality
Maximilian Stahl, Varun Narendra, Justin Jee, et al.
Cancer Biology & Therapy
|
December 14, 2007
Primary cardiac lymphoma: utility of multimodality imaging in diagnosis and management
Anthony R Mato, Alicia K Morgans, Michele R Roullet, et al.
American Journal of Hematology
|
March 26, 2016
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas
Clinton Yam, Daniel J Landsburg, Kevin T Nead, et al.
Cancer
|
December 20, 2011
Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD
Anthony R Mato, Jakub Svoboda, Tatyana Feldman, et al.
Cell Death & Disease
|
July 23, 2025
Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient
Johanne U Hermansen, Paschalis Athanasiadis, Yanping Yin, et al.
Page
of 10